Doxorubicin-enriched, ALDHbr mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1
© Zhuang et al.; licensee BioMed Central Ltd. 2012
Received: 7 June 2012
Accepted: 18 October 2012
Published: 23 November 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|7 Jun 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|8 Jun 2012||Author responded||Author comments - Xiufen Zhuang|
|Resubmission - Version 3|
|8 Jun 2012||Submitted||Manuscript version 3|
|2 Jul 2012||Reviewed||Reviewer Report - Samuel Rabkin|
|7 Jul 2012||Reviewed||Reviewer Report - Ya-Fang Mei|
|20 Jul 2012||Reviewed||Reviewer Report - Faris Farassati|
|5 Aug 2012||Author responded||Author comments - Xiufen Zhuang|
|Resubmission - Version 4|
|5 Aug 2012||Submitted||Manuscript version 4|
|17 Aug 2012||Author responded||Author comments - Xiufen Zhuang|
|Resubmission - Version 5|
|17 Aug 2012||Submitted||Manuscript version 5|
|18 Oct 2012||Editorially accepted|
|23 Nov 2012||Article published||10.1186/1471-2407-12-549|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.